Siemens Medical Systems has been active in forming alliances for its PACS program. At the Healthcare Information and Management Systems Society conference in February, the Iselin, NJ-based vendor entered into a strategic alliance with RIS firm IDX
Siemens Medical Systems has been active in forming alliances for its PACS program. At the Healthcare Information and Management Systems Society conference in February, the Iselin, NJ-based vendor entered into a strategic alliance with RIS firm IDX Systems. The two companies had been working together at the Cleveland Clinic, where they have integrated the multimodality vendors PACS and modality network with IDXs IDXrad RIS offering.
The nonexclusive agreement allows each company to jointly participate in marketing, sales, and installation efforts in North America. As a result of their collaboration at the Cleveland Clinic, Siemens and Burlington, VT-based IDX say they have achieved true integration of RIS and PACS, and have eliminated the need for a traditional PACS/RIS interface.
The agreement isnt the only PACS partnership announced by Siemens recently. The company has also formed a nonexclusive co-marketing agreement with archiving firm StorageTek. Staff from both Siemens and Louisville, CO-based StorageTek will meet jointly with clients in complicated PACS purchasing situations, according to the firms.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.